Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 21:30 | 10/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | King-Jones Heidy | MA | O | See Rema | 4 | M.dm | 5,946 | 51.85 | 0 | 115 | 3 | D | |||||||||||||||
10/2/26 21:30 | 10/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | King-Jones Heidy | MA | O | See Rema | 4 | S.dm | -5,946 | 51.85 | 0 | -115 | 3 | D | |||||||||||||||
10/2/26 21:29 | 10/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 3 | S | -4,122 | 91.60 | 0 | -45 | 568 | D | |||||||||||||||
10/2/26 21:29 | 9/30/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 6 | M.dm | 5,842 | 59.48 | 0 | 98 | 98 | D | |||||||||||||||
10/2/26 21:29 | 9/30/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 6 | S.dm | -5,842 | 59.48 | 0 | -98 | 98 | D | |||||||||||||||
8/10/26 21:31 | 8/7/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | 2 | M.d | 2,456 | 87.72 | 0 | 28 | 9 | M | ||||||||||||||||
8/10/26 21:31 | 8/7/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | 2 | S.d | -2,456 | 87.72 | 0 | -28 | 9 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |